NASDAQ:ONCE - Spark Therapeutics, Inc.
$96.45
 $-0.40
-0.41%
12:10PM EDT
2019-07-22
Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ONCE     avg for
industry  
  avg for
sector  
42 stocks weight:  89. 51   217. 37   399. 45  
42 stocks rank:  1. 85 K 1. 27 K 716. 99  
# analyst opinions:  16. 00   13. 21   13. 71  
mean recommendation:  2. 90   2. 10   2. 04  

quick ratio:  5. 08   5. 49   1. 88  
current ratio:  5. 94   5. 87   2. 36  

target price low:  48. 00   83. 44   114. 90  
target price avg:  105. 03   106. 20   137. 90  
target price high:  115. 00   132. 30   158. 97  
1-yr high:  114. 01   111. 86   142. 57  
last close:  96. 85   86. 79   125. 44  
50-day avg:  104. 16   86. 68   122. 63  
200-day avg:  76. 77   89. 22   121. 38  
1-yr low:  34. 70   69. 78   100. 51  
volume:  287. 54 K 2. 62 M 3. 43 M
50-day avg volume:  538. 42 K 3. 20 M 4. 16 M
200-day avg volume:  1. 02 M 2. 99 M 4. 75 M

1-day return:  -1. 35 % -1. 30 % -0. 99 %
this week return:  -1. 22 % 0. 45 % -0. 20 %
12-wk return:  -10. 22 % 0. 94 % 4. 84 %
52-wk return:  22. 13 % -1. 30 % 10. 55 %

enterprise value (EV):  3. 40 B 45. 10 B 122. 38 B
market cap:  3. 72 B 38. 96 B 108. 40 B
EBITDA:  -193. 13 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -17. 58   5. 38   11. 93  
enterprise/revenue (EV/R):  48. 63   57. 92   10. 21  
total revenue:  69. 82 M 9. 91 B 39. 98 B
total debt:  93. 80 M 10. 90 B 17. 48 B
debt/equity:  20. 80   57. 18   120. 05  
net income (common):  -86. 81 M 2. 07 B 4. 05 B

shares outstanding:  37. 57 M 538. 09 M 1. 24 B
shares:  37. 57 M 548. 00 M 1. 22 B
shares short:  3. 10 M 10. 98 M 11. 87 M
shares short prior month:  2. 24 M 9. 32 M 12. 05 M
short ratio:  4. 27   5. 60   3. 34  
short % of float:  8. 32 % 6. 48 % 2. 64 %
total cash/share:  10. 90   10. 98   9. 19  
total cash:  418. 78 M 5. 93 B 6. 10 B
free cash flow:  -35. 31 M 2. 92 B 4. 55 B
operating cash flow:  -155. 66 M 3. 80 B 5. 78 B

book value:  11. 76   13. 35   27. 45  
price/book:  8. 23   4. 60   8. 78  
gross profits:  56. 81 M 7. 44 B 36. 13 B
operating margins:  -287. 84 % -308. 40 % -28. 55 %
EBITDA margins:  -276. 61 % 13. 17 % 23. 38 %
profit margins:  -124. 33 % 10. 44 % 14. 18 %
gross margins:  85. 08 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 31   2. 10   4. 23  
forward EPS:  -4. 07   3. 45   7. 10  
P/E:  -41. 93   1. 90   32. 10  
forward P/E:  -23. 80   6. 46   15. 47  
PE/G:  -1. 29   0. 70   -0. 54  
growth:  32. 50 % 265. 63 % 79. 11 %
earnings high:  -0. 44   0. 89   1. 68  
earnings avg:  -1. 21   0. 70   1. 57  
earnings low:  -1. 75   0. 46   1. 46  
revenue high:  51. 00 M 2. 57 B 11. 07 B
revenue avg:  28. 43 M 2. 51 B 10. 91 B
revenue low:  15. 49 M 2. 45 B 10. 73 B
return on assets:  -17. 41 % -2. 34 % 5. 28 %
return on equity:  -18. 65 % -90. 08 % 133. 53 %
revenue growth:  32. 50 % 265. 25 % 73. 68 %
revenue/share:  1. 86   12. 72   60. 04  

beta (1yr vs S&P500):  1. 45   1. 27   0. 91  
sharpe (1yr):  0. 56   0. 16   0. 77  

held % insiders:  7. 45 % 6. 06 % 3. 29 %
held % institutions:  92. 25 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ONCE
.    145.201 =       145.201 :: --> INITIAL WEIGHT <--
.     - 2.31 =       142.891 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.     x 2.84 =       405.765 :: P/E factor
.    x 0.978 =        396.67 :: PE/G factor
.    x 1.549 =       614.392 :: beta factor
.    x 0.839 =        515.33 :: sharpe factor
.    x 2.988 =      1539.666 :: current ratio factor
.    x 1.116 =      1717.938 :: quick ratio factor
.    x 1.111 =      1908.529 :: short ratio factor
.      x 1.5 =      2863.106 :: revenue growth factor
.     x 1.84 =      5266.814 :: EV/R factor
.    x 1.094 =      5759.531 :: price-to-book factor
.    x 0.907 =      5224.513 :: debt-to-revenue factor
.    x 1.168 =      6101.016 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     12938.991 :: sector+industry 1-year gains factor
.    x 1.009 =     13060.981 :: industry 12-weeks return factor
.    x 1.308 =     17082.308 :: industry 2-weeks return factor
.    x 1.192 =     20362.111 :: company one-year gains+dividend factor
.    x 0.983 =     20021.256 :: company 13 weeks' performance factor
.    x 1.541 =     30853.499 :: 5-day avg > 200-day avg
.    x 1.357 =     41859.354 :: 50-day avg > 200-day avg
.    x 0.991 =     41469.594 :: "drift" penalty 5 days ago
.    / 1.821 =     22769.088 :: overall "drift" factor
.    x 0.881 =     20062.916 :: largest single-day jump factor
.        x 1 =     20062.916 :: volatility factor
.        x 1 =     20062.916 :: 42-day volatility factor
.    x 2.779 =     55747.115 :: notable returns + performance factor
.    x 3.342 =    186316.435 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.     x 0.64 =    119182.156 :: forward EPS factor
.    x 0.869 =    103577.087 :: forward P/E factor
.    x 1.185 =     122709.07 :: industry recommendation factor
.    x 1.638 =    200979.995 :: company recommendation factor
.    x 1.003 =    201535.782 :: factor historical industry gain for week 29
.    x 0.892 =    179691.126 :: target low factor
.    x 1.097 =    197098.458 :: target mean factor
.    x 1.018 =     200682.07 :: target high factor
.    x 8.561 =   1718084.284 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        36.204 :: reduced for readability
.   + 53.308 =        89.512 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     89.512 :: FINAL WEIGHT for NASDAQ:ONCE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org